Check out our most popular compounded medications! Get Started
Lubiprostone 24 Mcg/2.5 ml Oral Solution is a liquid formulation that contains active ingredients dissolved in a suitable solvent. It is intended for oral administration and is often used when a specific dosage strength or ease of swallowing is required. This medication is used to treat conditions such as Irritable Bowel Syndrome (IBS), Constipation, Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Gastroparesis. It offers accurate dosing and convenient delivery of medication.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Lubiprostone 24 Mcg/2.5 ml Oral Solution is a specially compounded prescription medication designed to treat a range of gastrointestinal conditions. These include Irritable Bowel Syndrome, Chronic Idiopathic Constipation, Opioid-Induced Constipation, Gastroparesis, and Constipation-Predominant Irritable Bowel Syndrome. The active ingredient, Lubiprostone, works by promoting the secretion of chloride and bicarbonate ions into the intestinal lumen. This action helps to soften the stool and facilitate its passage through the intestines.
This medication is presented in a liquid formulation, which offers accurate dosing and convenient delivery. The oral solution form is particularly beneficial for patients who require a specific dosage strength or have difficulty swallowing tablets or capsules. The liquid form allows for easy administration and absorption of the medication.
Clinical studies have demonstrated the effectiveness of Lubiprostone 24 Mcg/2.5 ml Oral Solution in alleviating the symptoms associated with the aforementioned gastrointestinal conditions. It is generally well tolerated by most patients. However, some may experience side effects such as nausea, diarrhea, and abdominal pain. It is important for patients to be monitored for any signs of adverse reactions and to consult their healthcare provider if any side effects occur.
At Bayview Pharmacy, we prioritize the health and well-being of our patients. We are dedicated to providing high-quality compounded medications tailored to meet individual patient needs. If you have any questions or concerns about Lubiprostone 24 Mcg/2.5 ml Oral Solution or any other medications, we encourage you to reach out to us. Our team is here to provide the support and information you need to manage your health effectively.
Lubiprostone 24 Mcg/2.5 ml Oral Solution is a liquid formulation designed for oral administration. It contains the active ingredient lubiprostone, which is dissolved in a suitable solvent. This formulation is particularly beneficial for patients requiring a specific dosage strength or those who have difficulty swallowing solid dosage forms. It offers accurate dosing and convenient delivery of medication.
This medication is indicated for the treatment of several conditions including Irritable Bowel Syndrome, Chronic Idiopathic Constipation, Opioid-Induced Constipation, Gastroparesis, and Constipation-Predominant Irritable Bowel Syndrome. Lubiprostone works by increasing the secretion of chloride and bicarbonate into the intestinal lumen. This action increases intestinal fluid and aids in softening the stool, thereby facilitating easier bowel movements.
It is crucial to note that lubiprostone should not be used in patients with severe diarrhea as it may exacerbate the condition. It is also contraindicated in patients with known or suspected mechanical gastrointestinal obstruction. Patients are advised to consume plenty of fluids while on this medication to prevent dehydration. They should be monitored for signs and symptoms of dehydration such as dry mouth, thirst, decreased urine output, and dizziness. If any of these symptoms occur, patients should immediately contact their healthcare provider.
Patients are also advised to take lubiprostone with food to minimize the risk of nausea. If any adverse reactions occur, patients should promptly contact their healthcare provider for guidance.
Lubiprostone 24 Mcg/2.5 ml Oral Solution is a compounded prescription medication primarily used in the treatment of various gastrointestinal disorders. These include Irritable Bowel Syndrome, Chronic Idiopathic Constipation, Opioid-Induced Constipation, Gastroparesis, and Constipation-Predominant Irritable Bowel Syndrome. The medication functions by promoting the secretion of chloride and bicarbonate into the intestinal lumen, which aids in softening the stool and facilitating its passage through the intestines.
The medication is designed for oral administration and can be taken with or without food, typically once or twice daily. The dosage and frequency of administration should be determined by a healthcare provider, based on the patient's specific condition and response to treatment. It is crucial to follow the prescribed dosage regimen to ensure the effectiveness of the medication and to minimize potential side effects.
Common side effects associated with Lubiprostone 24 Mcg/2.5 ml Oral Solution include nausea, diarrhea, abdominal pain, and flatulence. While these side effects are generally mild and temporary, patients should seek immediate medical attention if they experience severe or persistent side effects.
Lubiprostone 24 Mcg/2.5 ml Oral Solution is contraindicated in pregnant women due to potential risks to the fetus. It is also not recommended for patients with severe liver impairment. Patients should disclose their full medical history, including any existing medical conditions or allergies, to their healthcare provider before starting treatment. Additionally, patients should inform their healthcare provider about any other medications they are currently taking to avoid potential drug interactions.
Patients are encouraged to consult their healthcare provider or pharmacist if they have any questions or concerns about Lubiprostone 24 Mcg/2.5 ml Oral Solution. It is important to understand how to properly use this medication to ensure its effectiveness and to achieve the best possible treatment outcomes.
Lubiprostone 24 Mcg/2.5 ml Oral Solution is a liquid formulation that contains the active ingredient lubiprostone dissolved in a suitable solvent. This formulation is designed for oral administration, providing accurate dosing and convenient delivery of medication. It is often utilized when a specific dosage strength is required or when ease of swallowing is a concern for the patient.
While the primary use of Lubiprostone 24 Mcg/2.5 ml Oral Solution is for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults, it has also been used off-label for the management of fecal incontinence. Fecal incontinence is a condition characterized by the inability to control bowel movements, leading to involuntary leakage of stool.
Furthermore, Lubiprostone 24 Mcg/2.5 ml Oral Solution has been used to manage functional constipation, a condition where a patient experiences difficulty in passing stools despite having normal bowel movements. This can lead to discomfort, bloating, and straining during bowel movements.
Additionally, some patients have used Lubiprostone 24 Mcg/2.5 ml Oral Solution to alleviate symptoms of gastroesophageal reflux disease (GERD), such as heartburn and regurgitation. However, it is crucial to note that lubiprostone is not officially approved for the treatment of GERD.
If you have any questions or concerns about the use of Lubiprostone 24 Mcg/2.5 ml Oral Solution for any of these conditions, it is recommended to consult with a healthcare professional for personalized advice and guidance.
Lubiprostone 24 Mcg/2.5 ml Oral Solution is a liquid formulation that contains the active ingredient Lubiprostone. It is dissolved in a suitable solvent and is intended for oral administration.
The specific dosage strength of Lubiprostone 24 Mcg/2.5 ml is designed to provide accurate dosing.
Lubiprostone 24 Mcg/2.5 ml is in a liquid form to offer convenient delivery of medication. This form is often used when ease of swallowing is required, such as for children or elderly patients, or those with difficulty swallowing pills.
Like most medications, Lubiprostone 24 Mcg/2.5 ml Oral Solution should be stored in a cool, dry place, away from direct sunlight and out of reach of children. Always refer to the product label or ask your pharmacist for specific storage instructions.
No, the dosage of Lubiprostone 24 Mcg/2.5 ml Oral Solution should not be adjusted without consulting your healthcare provider.
If you miss a dose of Lubiprostone 24 Mcg/2.5 ml Oral Solution, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double up on doses.
Before starting any new medication, including Lubiprostone 24 Mcg/2.5 ml Oral Solution, you should always inform your healthcare provider about all the medications you are currently taking. This includes prescription medications, over-the-counter drugs, and dietary supplements.
Like all medications, Lubiprostone 24 Mcg/2.5 ml Oral Solution can cause side effects. Common side effects may include nausea, diarrhea, and stomach pain. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
Pregnant or breastfeeding women should consult their healthcare provider before taking any medication, including Lubiprostone 24 Mcg/2.5 ml Oral Solution. Your healthcare provider will be able to advise you on the potential risks and benefits.
The time it takes for Lubiprostone 24 Mcg/2.5 ml Oral Solution to work can vary depending on the individual and the condition being treated. It is important to take the medication as directed by your healthcare provider and not to stop taking it even if you feel better, unless advised by your healthcare provider.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
